Examining Persistence in Smokers With Schizophrenia
| Status: | Completed |
|---|---|
| Conditions: | Schizophrenia, Smoking Cessation, Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 1/19/2019 |
| Start Date: | January 2017 |
| End Date: | June 13, 2018 |
All participants will receive free weekly counseling (8- weeks) and free nicotine patches
(10-weeks). They will complete assessment measures commonly used in smoking cessation
studies. We hope to show that this treatment is feasible in this small pilot study before
comparing it to a more established treatment in a future randomized clinical trial.
(10-weeks). They will complete assessment measures commonly used in smoking cessation
studies. We hope to show that this treatment is feasible in this small pilot study before
comparing it to a more established treatment in a future randomized clinical trial.
This study is a non-randomized trial of a new psychosocial treatment for smoking cessation
(for smokers with schizophrenia) that is based on cognitive behavioral therapy for smoking
cessation - a commonly used approach. Participants will receive free weekly counseling (8-
weeks) and free nicotine patches (10-weeks). They will complete assessment measures commonly
used in smoking cessation studies. We hope to show that this treatment is feasible in this
small pilot study before comparing it to a more established treatment in a future randomized
clinical trial.
(for smokers with schizophrenia) that is based on cognitive behavioral therapy for smoking
cessation - a commonly used approach. Participants will receive free weekly counseling (8-
weeks) and free nicotine patches (10-weeks). They will complete assessment measures commonly
used in smoking cessation studies. We hope to show that this treatment is feasible in this
small pilot study before comparing it to a more established treatment in a future randomized
clinical trial.
Inclusion Criteria:
- Must be between 18 - 64 years old
- Must indicate commitment to quitting smoking in the next 30 days
- Must smoke at least 5 cigarettes per day for past 6-months
- Expired breath carbon monoxide (CO) > 5 to ensure daily cigarette use
- Must score < 8 (or <7 for women) on the Alcohol Use Disorders Identification Test
- Must score less than 3 on the 6-month Drug Abuse Screening Test-10
- Must provide a negative urine drug screen for cannabis, cocaine, opiates, or
- methamphetamine (Note: Participants with a positive screen for opiates may
- participate with proof of prescription for opiates.)
- Must have a diagnosis of Schizophrenia or Schizoaffective Disorder on Structured
Clinical Interview
- Psychiatric illness must be stable, as indicated by no hospitalizations in previous 8
weeks, and a stable psychotropic medication regimen including a stable antipsychotic
dose for 8 weeks
Exclusion Criteria:
- Must not be currently receiving tobacco dependence treatment counseling
- Must not currently be taking varenicline (Chantix)
- Must not be taking bupropion (Zyban/Wellbutrin) to quit smoking
- Must not be taking any nicotine preparations (gum, lozenge, patch, spray, inhaler)
daily over the last 10 days.
- Must not report unstable angina pectoris, myocardial infarction, or significant
cardiac arrhythmia (including atrial fibrillation) in the past 90 days
- Must not be pregnant, breastfeeding, or planning on becoming pregnant in the next
4-months. Women who can become pregnant may be included if using effective birth
control
- Must not have pending legal matters with potential to result in jail time
- Must not be planning on moving outside local area in next 3-months
We found this trial at
1
site
New Brunswick, New Jersey 08903
Principal Investigator: Marc L Steinberg, Ph.D.
Phone: 732-235-3904
Click here to add this to my saved trials
